2023

COVID-19 Antigen Results Correlate with the Quantity of Replication-Competent SARS-CoV-2 in a Cross-Sectional Study of Ambulatory Adults during the Delta Wave

Tu YP, Green C, Hao L, Greninger AL, Morton JF, Sights HA, Gale M Jr, Drain PK.
Microbiol Spectr. 2023 Apr 25:e0006423. doi: 10.1128/spectrum.00064-23. Online ahead of print. PMID: 37097146

Assessing Cytoskeletal Destruction During Pyroptosis

Davis MA, Gale M Jr.
Methods Mol Biol. 2023;2641:179-188. doi: 10.1007/978-1-0716-3040-2_15. PMID: 37074651

Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2.

Phan JM, Layton ED, Yu KKQ, Aguilar MS, Golez I, Franko NM, Logue JK, Rodda LB, Howard CA, Pepper M, Gale M, Chu HY, Seshadri C.
J Immunol. 2023 May 1;210(9):1236-1246. doi: 10.4049/jimmunol.2200815. PMID: 36961450

A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.

Hemann EA, Knoll ML, Wilkins CR, Subra C, Green R, García-Sastre A, Thomas PG, Trautmann L, Ireton RC, Loo YM, Gale M.
J Immunol. 2023 May 1;210(9):1247-1256. doi: 10.4049/jimmunol.2300026. PMID: 36939421

Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating Factor Receptor Expression.

Lin SJ, Lin KM, Chen SJ, Ku CC, Huang CW, Huang CH, Gale M Jr, Tsai CH.
J Virol. 2023 Apr;161:105420. doi: 10.1016/j.jcv.2023.105420. Epub 2023 Mar 3. PMID: 36913789

Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study.

Drain PK, Dalmat RR, Hao L, Bemer MJ, Budiawan E, Morton JF, Ireton RC, Hsiang TY, Marfatia Z, Prabhu R, Woosley C, Gichamo A, Rechkina E, Hamilton D, Montaño M, Cantera JL, Ball AS, Golez I, Smith E, Greninger AL, McElrath MJ, Thompson M, Grant BD, Meisner A, Gottlieb GS, Gale M Jr.
J Clin Virol. 2023 Apr;161:105420. doi: 10.1016/j.jcv.2023.105420. Epub 2023 Mar 3. PMID: 36913789

Programming cytomegalovirus as an HIV vaccine. .

Picker LJ, Lifson JD, Gale M Jr, Hansen SG, Früh K..
Trends Immunol.. 2023 Apr;44(4):287-304. doi: 10.1016/j.it.2023.02.001. Epub 2023 Mar 7. PMID: 36894436

Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron.

Hao L, Hsiang TY, Dalmat RR, Ireton R, Morton JF, Stokes C, Netland J, Hale M, Thouvenel C, Wald A, Franko NM, Huden K, Chu HY, Sigal A, Greninger AL, Tilles S, Barrett LK, Van Voorhis WC, Munt J, Scobey T, Baric RS, Rawlings DJ, Pepper M, Drain PK, Gale M Jr.
Viruses. 2023 Feb 14;15(2):530. doi: 10.3390/v15020530. PMID: 36851745